Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma.

Oliver, Thomas W.; Bernardino, Michael E.; Miller, Joseph I.; Mansour, Kamal A.; Greene, Damian; Davis, Wendy A.

doi:10.1148/radiology.153.1.6473783

Cited by 234 publications

(79 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The ®nding of an isolated adrenal mass on CT is often a diagnostic challenge. About two-thirds of cases could be explained by an asymptomatic adrenal adenoma in some series [110,113]. An adrenal mass, therefore does not imply inoperable disease, but rather the need for further (pathological) examination by, for example, puncture or biopsy of the lesion [113].…”

Section: Extrathoracic Staging (M Status)mentioning

confidence: 99%

The role of positron emission tomography with ¹⁸ F-fluoro-2-deoxy-D-glucose in respiratory oncology

Vansteenkiste

Stroobants

2001

Eur Respir J

View full text Add to dashboard Cite

In the past 5 yrs, positron emission tomography (PET) with18F-fluoro-2-deoxy-d-glucose (FDG) has become an important imaging modality in lung cancer patients. At this time, the indication of FDG-PET as a complimentary tool to computed tomography in the diagnosis and staging of non-small cell lung cancer has gradually gained more widespread acceptance and also reimbursement in many European countries.This review focuses on the data of FDG-PET in the diagnosis of lung nodules and masses, and in locoregional and extrathoracic staging of non-small cell lung cancer. Emphasis is put on the potential clinical implementation of the currently available FDG-PET data. The use of FDG-PET in these indications now needs further validation in large-scale multicentre randomized studies, focusing mainly on treatment outcome parameters, survival and cost-efficacy.Interesting findings with18F-fluoro-2-deoxy-d-glucose-positron emission tomography have also been reported for the evaluation of response to radio- or chemotherapy, in radiotherapy planning, recurrence detection and assessment of prognosis. Finally, a whole new field of application of positron emission tomography in molecular biology, using new radiopharmaceuticals, is under extensive investigation.

show abstract

Section: Extrathoracic Staging (M Status)mentioning

confidence: 99%

The role of positron emission tomography with ¹⁸ F-fluoro-2-deoxy-D-glucose in respiratory oncology

Vansteenkiste

Stroobants

2001

Eur Respir J

View full text Add to dashboard Cite

show abstract

“…Adrenal metastaz tanısı, akciğer kanseri olduğu bilinen ya da şüphelenilen bir hastada çekilen bilgisayarlı tomografinin (BT) kesitlerine giren adrenal kitle ya da evreleme taramaları sırasında konur. Opere edilen küçük hücreli dışı akciğer kanserlerinin incelendiği bir seride, 330 hastanın 32'sinde (%10) izole adrenal kitle tespit edilmiştir.Bunların yalnızca 8 tanesi (%25) maligndir, kalanların iyi huylu lezyonlar (adenom, nodüler hiperplazi, hemorajik kist) olduğu gösterilmiştir (28). Görüntülemenin negatif olması adrenal metastazı dışlamaz.…”

Section: Organ Metastazlariunclassified

Lung Cancer, Endocrınopathıes And Paraneoplastıc Syndromes

Akyay¹,

Selek²,

Tarkun³

2016

Toraks Cer Bult

View full text Add to dashboard Cite

Thyroid diseases and diabetes mellitus are the most common endocrine diseases. Lung cancer is also one of the most frequent cancer types observed worldwide. Therefore, diabetes and thyroid diseases are frequently observed in patients with lung cancer. The diagnosis and management of these diseases are important; hence, uncontrolled diabetes and thyroid diseases might increase postoperative mortality and morbidity rates. Endocrinologic paraneoplastic syndromes frequently accompany lung cancer. These diseases may be observed as the first sign of the disease or may cause a delay in treatment and an increase in mortality. In addition, lung cancer may metastasize to vital endocrine organs, causing hormonal insufficiencies that may be mortal if not treated. In patients with lung cancer, the treatment of comorbidities and coincidence diseases are as important as the treatment of primary diseases to decrease the mortality and morbidity rates.

show abstract

“…Indeed, examination of the adrenal glands can be done easily at the time of the CT examination of the chest. However, two-thirds of the adrenal masses identified by CT in patients with lung carcinoma are adenomas [91]. Most incidental nonhyperfunctioning adenomas arev3 cm in diameter and of uniform low attenuation (v10 Hounsfield units) because of their fat content ( fig.…”

Section: Evaluation Of Distant Metastasis: the M Factormentioning

confidence: 99%

Computed tomography in staging for lung cancer

Verschakelen¹,

Bogaert²,

Wever³

2002

Eur Respir J

View full text Add to dashboard Cite

Computed tomography (CT) provides the most detailed imaging information, hence it is generally used as a routine imaging procedure in the tumour, node, metastasis (TNM)-staging of patients with lung cancer. However, despite the continuously ongoing process of improvement in CT scanning in which today9s CT scanners combine fast acquisition, fast data reconstruction and high detail, the technique has important limitations.CT can, in some cases, very accurately show tumour extent within, and predict spread beyond the lung. However, the question of whether the tumour has invaded the chest wall or the mediastinum and, if so, whether it is still potentially surgically curable often remains unanswered. In addition, the only sign for predicting lymph node involvement using CT is enlargement. Many studies have shown that this sign is not very reliable. CT is also, with success, being used to evaluate distant metastases although other techniques such as ultrasound and magnetic resonance imaging can have similar or higher accuracies.Despite these well-known limitations, computed tomography will most likely stay the routine imaging procedure for determining resectability and for assessing intra-and extrathoracic spread of lung cancer. The improvement in technology will probably result a better T-staging. The role of computed tomography in nodal staging remains important. It offers the surgeon a road map of the lymph nodes and guides towards the nodes that need biopsy. Combining computed tomography with positron emission tomography, when it becomes more widely available, will add functional images to the detail of computed tomography and will not only improve nodal staging but will probably also allow a better evaluation of distant metastasis and reduce the number of unnecessary interventional procedures.

show abstract

Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma.

Cited by 234 publications

References 0 publications

The role of positron emission tomography with ¹⁸ F-fluoro-2-deoxy-D-glucose in respiratory oncology

The role of positron emission tomography with ¹⁸ F-fluoro-2-deoxy-D-glucose in respiratory oncology

Lung Cancer, Endocrınopathıes And Paraneoplastıc Syndromes

Computed tomography in staging for lung cancer

Contact Info

Product

Resources

About

Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma.

Cited by 234 publications

References 0 publications

The role of positron emission tomography with 18 F-fluoro-2-deoxy-D-glucose in respiratory oncology

The role of positron emission tomography with 18 F-fluoro-2-deoxy-D-glucose in respiratory oncology

Lung Cancer, Endocrınopathıes And Paraneoplastıc Syndromes

Computed tomography in staging for lung cancer

Contact Info

Product

Resources

About

The role of positron emission tomography with ¹⁸ F-fluoro-2-deoxy-D-glucose in respiratory oncology

The role of positron emission tomography with ¹⁸ F-fluoro-2-deoxy-D-glucose in respiratory oncology